Objective This study examined symptom-based subgroups of metastatic breast cancer (MBC) patients and the extent to which they differed across key constructs of acceptance and commitment therapy (ACT).
of these symptoms. 3, 6, 11 Other common symptoms among cancer patients (eg, nausea, neuropathy, swelling of arms and legs, hot flashes, and cognitive problems) have received less attention in the MBC literature. 6, [12] [13] [14] Preliminary evidence suggests that symptoms may disrupt the daily activities of MBC patients. 3, 15 One study found that greater symptom severity and interference were associated with greater daily activity impairment and reduced work productivity in this population. 3 Another study of MBC patients found that greater depressive symptoms predicted increases in global perceptions of activity disruption during a 3-month period. 15 To date, intervention trials to reduce symptoms and distress have been largely ineffective for MBC patients. 16 According to a recent
Cochrane meta-analysis, 16 nonpharmacological interventions for MBC patients, most of which were cognitive-behavioral or emotionfocused group therapy, have only yielded short-term benefits with respect to pain and distress reduction. Cognitive-behavioral therapy is a problem-focused approach with a primary goal of symptom reduction. Novel intervention models seek to shift the emphasis from symptom reduction to decreasing symptom-related suffering and interference with valued activities. 17 Given that symptom-related suffering and interference are focal points of palliative care for advanced cancer patients, 18 these novel intervention models might be particularly well suited for MBC patients.
One psychological intervention that holds promise for reducing symptom-related suffering and functional interference in cancer patients is acceptance and commitment therapy (ACT). 19 ACT promotes psychological flexibility so that internal experiences (eg, thoughts, feelings, and bodily sensations) do not impair patients' ability to live a meaningful life. 20 Psychological flexibility is defined as the ability to fully experience the present moment, including thoughts and feelings, while persisting in value-based action. 17 This flexibility has been associated with reduced anxiety and depressive symptoms and better well-being in patients with common cancers. 21, 22 Conversely, psychological inflexibility occurs when people avoid unwanted thoughts and emotions, which often has the paradoxical effect of increasing distress and decreasing value-based action. 17 From an ACT perspective, values are patient-defined life directions (eg, showing love and promoting justice) that are intrinsically reinforcing and provide a sense of meaning and purpose. 17 ACT has been successfully applied to a range of clinical disorders, including anxiety, depression, and posttraumatic stress disorder. 23 In addition, ACT has shown promising effects on psychological distress, quality of life, and self-management among patients with medical conditions such as diabetes and chronic pain. 24, 25 A small number of pilot studies-most of which were not randomized trials-have examined the efficacy of ACT in cancer patients. 26 However, 1 randomized trial with late-stage ovarian cancer patients found large improvement in mood and quality of life among ACT participants compared with those assigned to cognitive-behavioral therapy. 27 Despite the promising evidence presented previously, several remaining questions need to be answered before investing resources into developing an ACT intervention for MBC patients. Most importantly, research is needed to establish links between key ACT constructs (ie, activity engagement, psychological inflexibility, value obstruction, and value progress) and symptom burden in MBC patients. The current study aims to take this critical next step. Drawing upon ACT theory 17 and previous research, 21, 22 we expected that patient subgroups with higher symptom levels would report less activity engagement, greater psychological inflexibility and value obstruction, and less value progress than subgroups with lower symptom levels. Research assistants mailed letters inviting study participation and consent forms to patients and called them to screen for eligibility and complete the informed consent process. Patients were excluded from study participation if they made 3 or more errors on a validated 6-item cognitive screener that has been widely used with cancer patients. 28 Sample items include "What year is this?" and "What month is this?"
At the time of enrollment, patients received a brochure that described available mental health services at the cancer center.
Of the 107 MBC patients who received mailed information about this study, 85 (79%) completed the screening assessment, 12 (11%)
could not be reached via phone, and 10 (9%) refused study participation. Primary reasons for refusal were time constraints and health concerns. Of those who completed screening, 2 were found to be ineligible, and 83 were eligible and consented to participate.
Eighty patients (96%) completed a standardized phone assessment consisting of the measures described in the following sections.
Patients received a $40 gift card for their participation.
| Measures

| Physical and psychological symptoms
Ten common physical and psychological symptoms were assessed.
Four-item NIH Patient-Reported Outcomes Measurement Information
System (PROMIS) measures 29, 30 were used to assess the severity of the following symptoms: anxiety, depressive symptoms, sleep disturbance, fatigue, and general cognitive concerns. In addition, a 3-item PROMIS measure of pain intensity was used. 30 For all items, respondents selected 1 of 5 response options that best described their symptom level during the past 7 days. These measures have undergone rigorous reliability and validity testing. [29] [30] [31] PROMIS measures were initially developed with cancer patients' input, 32 and a growing body of research has documented the measures' reliability and validity for use with cancer patients, including those with advanced disease. [33] [34] [35] PROMIS measures of nausea, hot flashes, swelling of arms or legs, and neuropathy have yet to be developed. Thus, alternative measures of these symptoms were used, including 11 questions from the Memorial Symptom Assessment Scale 36 to assess nausea, swelling of arms and legs, and neuropathy during the past week. In addition, a 3-item validated assessment of hot flashes during the past 2 weeks was used. 37 Questions for each of these measures first assessed the presence of a symptom (yes or no), followed by Likert-type scales to assess symptom frequency, severity, and distress or bother. For swelling and hot flashes, only severity and distress or bother were assessed.
| Engagement in roles and activities
A 6-item PROMIS measure 29, 30 was used to assess engagement in roles and activities. Sample items are "I have to limit the things I do for fun with others" and "I have trouble doing all of my usual work
(including work at home)." Items were rated on a scale from 5 (never) to 1 (always). Items were reverse scored and summed, with higher scores indicating greater engagement in roles and activities. As stated earlier, PROMIS measures have undergone extensive validation.
29-31
| Psychological inflexibility
The 7-item Acceptance and Action Questionnaire II (AAQ-II) 38 was used to assess psychological inflexibility or difficulty pursuing effective behavior when having unwanted internal experiences. A sample item is "My painful experiences and memories make it difficult for me to live a life that I would value." Items were rated on a scale from 1 (never true) to 7 (always true). The AAQ-II demonstrated good test-retest reliability and discriminant validity. 
| Demographic and medical information
Patients reported their demographic information. Age, date of diagnosis, and treatments were collected from medical records.
| Statistical analysis
Data were analyzed with the Statistical Package for the Social Sciences functional status and quality of life. 40 Thus, patients with higher symptom burden were expected to show worse study outcomes compared to those with lower symptom burden. Differences between the clusters on demographic and medical factors were assessed using chisquare tests and 1-way analyses of variance (ANOVAs) followed by Tukey HSD tests. One-way ANOVAs and Tukey HSD tests also were performed to examine differences between patient clusters on the 10 symptoms, activity engagement, psychological inflexibility, value obstruction, and value progress. Two-sided P values of .05 were considered statistically significant.
3 | RESULTS
| Preliminary analyses
Sample characteristics are found in Table 1 Descriptive statistics, Cronbach alphas, and intercorrelations for the main study variables are found in Table 2 . All measures showed acceptable internal consistency reliability (α range = .75 to .95). As expected, nearly all symptoms showed significant, negative 
| Primary analyses
A hierarchical agglomerative cluster analysis was conducted to derive participant clusters based on the severity of the 10 symptoms. A 3-cluster solution was found. Cluster 1 was labeled "low symptoms,"
as it comprised 47 people with low symptom levels across domains.
Cluster 2 was labeled "low-moderate symptoms" and comprised 14 people with low to moderate symptom levels across domains.
Cluster 3 was labeled "moderate-high symptoms," as 19 people reported moderate to high symptom levels across domains. No significant differences were found among the clusters on demographic variables (ie, age, income, education, employment status, and marital status) and medical factors (ie, surgery, radiation, chemotherapy, hormonal therapy, and time since diagnosis).
One-way ANOVAs revealed significant differences between clusters on ratings of the 10 symptoms (see Table 3 ). Tukey post hoc comparisons showed that cluster 1 frequently had lower symptom levels than the other clusters, and cluster 2 had lower symptom levels than cluster 3 for hot flashes and fatigue.
One-way ANOVAs also revealed significant differences between clusters on activity engagement, psychological inflexibility, and value obstruction (see Table 3 ). Tukey comparisons showed that cluster 1 had greater activity engagement than the other clusters, which did not significantly differ from one another. Tukey comparisons also showed that cluster 1 had lower levels of psychological inflexibility and value obstruction than cluster 3. The 3 clusters did not differ from one another with respect to value progress.
| CONCLUSIONS
This study is the first to identify subgroups of patients with MBC based on ratings of common symptoms and their associations with key ACT constructs (ie, activity engagement, psychological inflexibility, value obstruction, and value progress). Results suggested that there were 3 patient subgroups: those with low symptoms, low-moderate symptoms, and moderate-high symptoms. Previous research with other cancer populations has also found heterogeneity with respect to patients' symptom experience. 40 In this study, compared with patients with low symptoms, the other patient subgroups reported less activity engagement. Furthermore, relative to patients with low symptoms, the subgroup with moderate to high symptom levels reported Another key finding of this study was that greater psychological inflexibility and higher symptom levels were related to reduced activity engagement and greater value obstruction. Similarly, a previous study of cancer patients found that greater psychological inflexibility was associated with less success in value-based living in certain domains (eg, family and leisure). 21 Consistent with these findings, ACT theorists have proposed that psychological suffering results from attempts to avoid aversive experiences, such as symptoms, which often lead to disengagement from valued activities. Despite commonly used pharmacological approaches to symptom management, MBC patients have high symptom burden that is a major source of suffering, impairment, and disability. [2] [3] [4] 6 Standard nonpharmacological approaches such as cognitive-behavioral therapy show limited evidence for reducing the symptom-related suffering of MBC patients. 16 ACT differs from traditional cognitive-behavioral approaches by emphasizing mindfulness, acceptance, and actions based on personal values. The current findings in combination with previous research 21, 22, 26 support investigating ACT as an intervention to reduce symptom interference and promote value-based living in this population. 
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